Jianxiong Zheng - Guangzhou Baiyunshan Deputy Mang

GU5 Stock  EUR 2.14  0.04  1.90%   

Insider

Jianxiong Zheng is Deputy Mang of Guangzhou Baiyunshan Pharmaceutical
Age 53
Phone86 20 6628 1218
Webhttps://www.gybys.com.cn

Guangzhou Baiyunshan Management Efficiency

The company has return on total asset (ROA) of 0.0356 % which means that it generated a profit of $0.0356 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1281 %, meaning that it generated $0.1281 on every $100 dollars invested by stockholders. Guangzhou Baiyunshan's management efficiency ratios could be used to measure how well Guangzhou Baiyunshan manages its routine affairs as well as how well it operates its assets and liabilities.
Guangzhou Baiyunshan Pharmaceutical has accumulated 752.81 M in total debt with debt to equity ratio (D/E) of 0.36, which is about average as compared to similar companies. Guangzhou Baiyunshan has a current ratio of 1.61, which is within standard range for the sector. Debt can assist Guangzhou Baiyunshan until it has trouble settling it off, either with new capital or with free cash flow. So, Guangzhou Baiyunshan's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Guangzhou Baiyunshan sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Guangzhou to invest in growth at high rates of return. When we think about Guangzhou Baiyunshan's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Belen MDMerck Company
63
FCS FCISCanSino Biologics
46
Guoqiang LinHANSOH PHARMAC HD 00001
76
ShouBai ChaoCanSino Biologics
60
Michael FlemingMerck Company
60
Joshua SmileyElanco Animal Health
49
Kazuhide NakatomiHisamitsu Pharmaceutical Co
51
Carl McMillianElanco Animal Health
51
Yuan SunHANSOH PHARMAC HD 00001
32
Friederike RotschMerck Company
51
Christopher OReillyTakeda Pharmaceutical
N/A
Matthias HeinzelMerck Company
56
Shiu WaiCanSino Biologics
55
Marcela KirbergerElanco Animal Health
56
Denise ScotsKnightElanco Animal Health
59
Deborah KochevarElanco Animal Health
62
Jin CuiCanSino Biologics
32
Zhu XinCanSino Biologics
50
Kirk McDonaldElanco Animal Health
52
Seigo IzumoTakeda Pharmaceutical
N/A
David KinardElanco Animal Health
56
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the Peoples Republic of China and internationally. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China. GUANG BAIY operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 25168 people. Guangzhou Baiyunshan Pharmaceutical (GU5) is traded on Frankfurt Exchange in Germany and employs 25,437 people.

Management Performance

Guangzhou Baiyunshan Leadership Team

Elected by the shareholders, the Guangzhou Baiyunshan's board of directors comprises two types of representatives: Guangzhou Baiyunshan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guangzhou. The board's role is to monitor Guangzhou Baiyunshan's management team and ensure that shareholders' interests are well served. Guangzhou Baiyunshan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guangzhou Baiyunshan's outside directors are responsible for providing unbiased perspectives on the board's policies.
Xiaoping Chu, Independent Director
Changhai Wu, Executive Deputy General Manager, Executive Director
Xuezhen Huang, Secretary of the Board
Zhang Chunbo, Deputy Director
Haiwen Huang, Deputy General Manager
Jun Yang, Executive Director
Weihong Wang, Independent Director
Chunbo Zhang, Deputy General Manager, Executive Director
Juyan Liu, Executive Director
Chuyuan Li, Chairman of the Board, Executive Director
Hong Li, General Manager, Executive Director
Haoshan Zheng, Deputy General Manager
Xianrong Huang, Independent Director
Jianxiong Zheng, Deputy Mang
Ning Cheng, Vice Chairman of the Board, Executive Director
Wenqi Jiang, Independent Director

Guangzhou Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Guangzhou Baiyunshan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Guangzhou Stock

Guangzhou Baiyunshan financial ratios help investors to determine whether Guangzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangzhou with respect to the benefits of owning Guangzhou Baiyunshan security.